16-1220680-C-T

Variant summary

Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2

The NM_021098.3(CACNA1H):​c.6748C>T​(p.Arg2250Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000367 in 1,609,328 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000039 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000036 ( 0 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

1
5
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: 1.24
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.11096549).
BP6
Variant 16-1220680-C-T is Benign according to our data. Variant chr16-1220680-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 643534.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Benign=1}.
BS2
High AC in GnomAd4 at 6 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CACNA1HNM_021098.3 linkuse as main transcriptc.6748C>T p.Arg2250Cys missense_variant 35/35 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkuse as main transcriptc.6748C>T p.Arg2250Cys missense_variant 35/351 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000565831.6 linkuse as main transcriptc.6730C>T p.Arg2244Cys missense_variant 33/331 ENSP00000455840.1 O95180-2
CACNA1HENST00000638323.1 linkuse as main transcriptc.6709C>T p.Arg2237Cys missense_variant 35/355 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000569107.5 linkuse as main transcriptc.2986C>T p.Arg996Cys missense_variant 17/171 ENSP00000454990.2 H3BNT0
CACNA1HENST00000564231.5 linkuse as main transcriptc.2938C>T p.Arg980Cys missense_variant 18/181 ENSP00000457555.2 H3BUA8
CACNA1HENST00000562079.5 linkuse as main transcriptc.2920C>T p.Arg974Cys missense_variant 17/171 ENSP00000454581.2 H3BMW6
CACNA1HENST00000639478.1 linkuse as main transcriptn.*1796C>T non_coding_transcript_exon_variant 35/355 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkuse as main transcriptn.*4566C>T non_coding_transcript_exon_variant 35/355 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000639478.1 linkuse as main transcriptn.*1796C>T 3_prime_UTR_variant 35/355 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkuse as main transcriptn.*4566C>T 3_prime_UTR_variant 35/355 ENSP00000491488.1 A0A1W2PQ19

Frequencies

GnomAD3 genomes
AF:
0.0000395
AC:
6
AN:
151990
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000966
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000194
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000513
AC:
12
AN:
233732
Hom.:
0
AF XY:
0.0000622
AC XY:
8
AN XY:
128520
show subpopulations
Gnomad AFR exome
AF:
0.000358
Gnomad AMR exome
AF:
0.0000298
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000998
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000293
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000364
AC:
53
AN:
1457338
Hom.:
0
Cov.:
35
AF XY:
0.0000373
AC XY:
27
AN XY:
724814
show subpopulations
Gnomad4 AFR exome
AF:
0.000120
Gnomad4 AMR exome
AF:
0.0000453
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000253
Gnomad4 SAS exome
AF:
0.0000465
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000351
Gnomad4 OTH exome
AF:
0.0000498
GnomAD4 genome
AF:
0.0000395
AC:
6
AN:
151990
Hom.:
0
Cov.:
32
AF XY:
0.0000404
AC XY:
3
AN XY:
74230
show subpopulations
Gnomad4 AFR
AF:
0.0000966
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000194
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000225
Hom.:
0
Bravo
AF:
0.0000756
ESP6500AA
AF:
0.000266
AC:
1
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000500
AC:
6

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Epilepsy, childhood absence, susceptibility to, 6;C4310756:Hyperaldosteronism, familial, type IV Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsApr 09, 2022- -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsAug 26, 2024The c.6748C>T (p.R2250C) alteration is located in exon 35 (coding exon 34) of the CACNA1H gene. This alteration results from a C to T substitution at nucleotide position 6748, causing the arginine (R) at amino acid position 2250 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpApr 27, 2023- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.35
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Benign
0.24
T;.;.;.
Eigen
Benign
-0.13
Eigen_PC
Benign
-0.094
FATHMM_MKL
Benign
0.13
N
LIST_S2
Uncertain
0.89
D;D;D;.
M_CAP
Pathogenic
0.43
D
MetaRNN
Benign
0.11
T;T;T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Uncertain
2.3
M;.;.;.
PrimateAI
Uncertain
0.59
T
PROVEAN
Benign
-2.0
N;.;N;N
REVEL
Benign
0.089
Sift
Uncertain
0.012
D;.;D;D
Sift4G
Benign
0.15
T;.;T;T
Polyphen
0.0060
B;.;B;B
Vest4
0.40
MVP
0.38
ClinPred
0.039
T
GERP RS
3.5
Varity_R
0.19
gMVP
0.24

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs375586314; hg19: chr16-1270680; API